Showing 2,661 - 2,680 results of 12,750 for search '"therapeutics"', query time: 0.11s Refine Results
  1. 2661
  2. 2662

    NF2 can mediate the expression of CAMK2A in a tissue specific manner by Zhaoying Lei, Huajian Cai, Qingfeng Yan

    Published 2024-12-01
    “…Thus, targeting CAMK2A may represent a promising strategy for drug screening and the development of therapeutics for NF2-associated meningiomas and other nervous system tumors.…”
    Get full text
    Article
  3. 2663
  4. 2664

    Toxicological Implications of Platinum Nanoparticle Exposure: Stimulation of Intracellular Stress, Inflammatory Response, and Akt Signaling In Vitro by Claudia J. Labrador-Rached, Rebecca T. Browning, Laura K. Braydich-Stolle, Kristen K. Comfort

    Published 2018-01-01
    “…Due to their distinctive physicochemical properties, platinum nanoparticles (PtNPs) have emerged as a material of interest for a number of biomedical therapeutics. However, in some instances NP exposure has been correlated to health and safety concerns, including cytotoxicity, activation of cellular stress, and modification to normal cell functionality. …”
    Get full text
    Article
  5. 2665
  6. 2666

    miRNA changes associated with differentiation of human embryonic stem cells into human retinal ganglion cells by Maryam Esmaeili, Daniel A. Smith, Ben Mead

    Published 2024-12-01
    “…The latter has led to interest in them as both biomarkers and as potential therapeutics. Retinal ganglion cells (RGC), whose axons connect the eye to the brain, are central nervous system cells of great interest, yet their study is largely restricted to animals due to the difficulty in obtaining healthy human RGC. …”
    Get full text
    Article
  7. 2667

    Bioprinting approaches in cardiac tissue engineering to reproduce blood-pumping heart function by Minji Kim, Dong Gyu Hwang, Jinah Jang

    Published 2025-01-01
    “…Engineered heart tissues have been introduced to reproduce heart functions to understand the pathophysiological properties of the heart and to test and develop potential therapeutics. Although numerous studies have been conducted in various fields to increase the functionality of heart tissue to be similar to reality, there are still many difficulties in reproducing the blood-pumping function of the heart. …”
    Get full text
    Article
  8. 2668

    The Drug Excipient Cyclodextrin Interacts With -Luciferin and Interferes With Bioluminescence Imaging by Jeyan S. Kumar MSc, Lisa M. Miller Jenkins PhD, Michael M. Gottesman MD, Matthew D. Hall PhD

    Published 2016-01-01
    “…As such, cyclodextrins are used as excipients for experimental therapeutics in vivo. We observed unanticipated modifications to bioluminescence imaging (BLI) signal intensity when 2-hydroxy-propyl-β-cyclodextrin (HPCD) was coinjected as an excipient. …”
    Get full text
    Article
  9. 2669

    Dynamic Analysis of the Blood-Brain Barrier Disruption in Experimental Stroke Using Time Domain in Vivo Fluorescence Imaging by Abedelnasser Abulrob, Eric Brunette, Jacqueline Slinn, Ewa Baumann, Danica Stanimirovic

    Published 2008-11-01
    “…The blood-brain barrier (BBB) disruption following cerebral ischemia can be exploited to deliver imaging agents and therapeutics into the brain. The aim of this study was (a) to establish novel in vivo optical imaging methods for longitudinal assessment of the BBB disruption and (b) to assess size selectivity and temporal patterns of the BBB disruption after a transient focal ischemia. …”
    Get full text
    Article
  10. 2670

    Functions and applications of RNA interference and small regulatory RNAs by Feng Xuezhu, Guang Shouhong

    Published 2024-11-01
    “…Additionally, we provide an overview of the applications of RNAi technology in biomedical research, agriculture, and therapeutics.…”
    Get full text
    Article
  11. 2671

    Induced Pluripotent Stem Cells and Outer Retinal Disease by Jin Yang, Bingcui Cai, Patrick Glencer, Zhiqing Li, Xiaomin Zhang, Xiaorong Li

    Published 2016-01-01
    “…For this reason, research about exploring retinal diseases’ underlying molecular mechanisms and potential therapeutic approach using stem cell technique has been developing rapidly. …”
    Get full text
    Article
  12. 2672

    Glucose metabolism impairment in major depressive disorder by Fanhao Meng, Jing Wang, Long Wang, Wei Zou

    Published 2025-02-01
    “…In addition, we briefly discussed potential pharmacological interventions for glucose metabolism to alleviate MDD, including glucagon-like peptide-1 receptor agonists, metformin, topical insulin, liraglutide, and pioglitazone, to encourage the development of new therapeutics.…”
    Get full text
    Article
  13. 2673
  14. 2674
  15. 2675
  16. 2676

    Crossing the Vascular Wall: Common and Unique Mechanisms Exploited by Different Leukocyte Subsets during Extravasation by Michael Schnoor, Pilar Alcaide, Mathieu-Benoit Voisin, Jaap D. van Buul

    Published 2015-01-01
    “…Therefore, a better understanding of the key molecules that regulate this process may help to develop novel therapeutics for treatment of inflammation-based diseases such as atherosclerosis or rheumatoid arthritis. …”
    Get full text
    Article
  17. 2677
  18. 2678

    Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein by Ioannis Papaioannou, J. Paul Simons, James S. Owen

    Published 2012-01-01
    “…Here, we describe atheroprotective properties of ApoE, though also potential proatherogenic actions, and the prevalence of dysfunctional isoforms, outline conventional gene transfer strategies, and then focus on gene correction therapeutics that can repair defective APOE alleles. …”
    Get full text
    Article
  19. 2679

    Interaction of RECQL4 with poly(ADP‐ribose) is critical for the DNA double‐strand break response in human cells by Sunyoung Shin, Dongmin Kim, Hyemi Kim, Won‐Ho Cho, Gyungmin Kim, Joon‐Kyu Lee

    Published 2025-01-01
    “…These results suggest that the direct interaction of RECQL4 with PAR is critical for proper cellular response to DSBs and provide insights to understand PARylation‐dependent control of the DSB response and cancer therapeutics using PARylation inhibitors.…”
    Get full text
    Article
  20. 2680

    Recurrent Catatonia due to Episodic Obsessive-Compulsive Disorder by Soumitra Das, Sakshi Prasad, Palak Atul Fichadia, Abhigan Babu Shrestha, Ozge C. Amuk Williams, Anil Bachu

    Published 2022-01-01
    “…Additionally, robust studies are needed in order to determine the pathophysiology of catatonia and the mechanism of ECT so that more beneficial therapeutics can be developed. A combination of ECT and antidepressants with ERP therapy for recurrent catatonia with OCD could be effective as a therapeutic modality.…”
    Get full text
    Article